-
-
-
-
-
-
-
PharmaCorp closes three pharmacy acquisitions across Canada
-
-
-
-
-
-
-
Palatin Technologies (PTN) Reports Positive Appetite Suppression Results From Phase 2 Obesity Study of MC4R Agonist Bremelanotide and Tirzepatide
-
-
-
-
-
-
-
Palatin Technologies (PTN) Tops Q2 EPS by 39c
-
-
-
-
-
-
-
Palatin Technologies (PTN) Misses Q1 EPS by 18c
-
-
-
-
-
-
-
Palatin Technologies (PTN) Reports FDA Confirmed Acceptability of Remaining Phase 3 Trials for PL9643
-
-
-
-
408,632 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

